Clinical Trial Update: Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration [NA]

View source ↗

Summary

Clinical trial update analyzing growth factors in patients receiving Lucentis or Avastin injections for diabetic macular edema and wet age-related macular degen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Wet Age-related Macular Degeneration

Drugs mentioned

• Avastin (bevacizumab)
• Lucentis (ranibizumab)

Snippet

Sponsor: Vitreo-Retinal Associates, Michigan | Conditions: Exudative Macular Degeneration, Diabetic Macular Edema | NA | Status: COMPLETED